{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69c6aa4bc2759aa9b124f8f4/6ab1633535231e4f55b4dcce?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"‘Nobody Called’: Katalin Karikó on the mRNA breakthrough that changed medicine","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69c6aa4bc2759aa9b124f8f4/1790010061370-4310fbe2-1aa4-4427-a7de-826389ebd8af.jpeg?height=200","description":"<p>Decades of curiosity and determination helped Katalin Karikó turn overlooked research into a technology that changed the course of a pandemic. The mRNA pioneer and Nobel laureate joins Søren and AJ to discuss how she navigated demotion and threats of deportation to find peace and joy in the lab.</p><p><br></p><p>Kati grew up in Hungary before leaving with her family to start a new life in the US – smuggling money hidden in her daughter’s teddy bear as she left.</p><p><br></p><p>She faced a language barrier and intense career headwinds upon arrival in the States. Then, one day, a serendipitous encounter with Drew Weissman at a photocopier triggered a collaboration that would lead to one of medicine’s biggest breakthroughs and the <a href=\"https://www.nobelprize.org/prizes/medicine/2023/press-release/\" rel=\"noopener noreferrer\" target=\"_blank\">2023 Nobel Prize in Physiology or Medicine</a>.</p><p><br></p><p>Kati talks about rejected grants, losing academic positions, and finding a new home for her research at BioNTech. She reflects on what it was like receiving the phone call confirming the COVID-19 vaccine worked. Søren and AJ reflect on the myriad uses for mRNA tech beyond vaccines and Kati explains why scientists need to get better at talking about what they do to prevent misinformation from filling the gaps.</p><p><br></p><p><strong>In this episode</strong></p><p><br></p><ul><li>04:18 – Explainer: What is mRNA and why does it matter?</li><li>09:04 – Nourishing a thirst for science in Hungary</li><li>15:20 – How Kati found her way into RNA research</li><li>16:53 – Leaving Hungary and starting again in the US</li><li>24:08 – Facing unemployment and the threat of deportation</li><li>29:01 – Meeting Drew Weissman at the photocopier</li><li>36:34 – “Nobody was interested”: when a breakthrough goes unnoticed</li><li>38:54 – Losing her position at Penn and finding a way forward</li><li>44:16 – Founding RNARx and the trouble with university patents</li><li>48:49 – Finding a new home for mRNA research at BioNTech</li><li>51:03 – The call that confirmed the COVID vaccine worked</li><li>52:49 – What could mRNA do beyond vaccines? </li><li>55:24 – Why scientists need to explain their work</li><li>60:01 – Being an immigrant and a woman in science</li><li>63:38 – Learning to handle setbacks and keep going</li><li>65:46 – Wrap-up and key takeaways</li><li>71:11 – Season one reflections</li></ul><p><br></p><p><strong>About the guest </strong></p><p>Katalin Karikó is a biochemist whose pioneering work with Drew Weissman helped make mRNA vaccines and therapeutics possible. After decades working on the technology in academic labs and later at BioNTech, Kati was awarded the 2023 Nobel Prize in Physiology or Medicine alongside Weissman. She is currently a professor at the University of Szeged and an adjunct professor at the University of Pennsylvania.</p><p><br></p><p><em>Dose of Discovery</em> is cohosted by Søren Hough and Ayokunmi Ajetunmobi (AJ) and produced by Suze Cooper.</p><p><br></p><p><strong>Read more</strong></p><p><a href=\"https://www.bioprocessintl.com/therapeutic-class/from-not-likely-to-nobel-prize-mrna-s-rise-to-fame\" rel=\"noopener noreferrer\" target=\"_blank\">From not likely to Nobel Prize: mRNA’s rise to fame</a> by Millie Nelson (<em>BioProcess Insider</em>)</p><p><br></p><p><a href=\"https://www.bioxconomy.com/modalities/experts-reject-hhs-officials-disparagement-of-mrna-technology\" rel=\"noopener noreferrer\" target=\"_blank\">‘Absolutely horrified’: Experts reject HHS officials’ disparagement of mRNA technology</a> by Søren Hough</p><p><br></p><p><a href=\"https://www.bioxconomy.com/modalities/improving-the-chances-of-parenthood-with-endometrium-targeted-mrna\" rel=\"noopener noreferrer\" target=\"_blank\">Improving parenthood chances with endometrium-targeted mRNA</a> by Millie Hoe</p><p><br></p><p><a href=\"https://www.bioxconomy.com/modalities/ai-designed-bespoke-mrna-therapy-reduces-melanoma-recurrence-metastasis-and-death\" rel=\"noopener noreferrer\" target=\"_blank\">AI-designed, bespoke mRNA therapy reduces melanoma recurrence, metastasis, and death</a> by Søren Hough</p><p><br></p><p><a href=\"https://www.bioxconomy.com/modalities/transcript-in-the-machine-how-ai-paved-the-way-for-customized-cancer-treatments\" rel=\"noopener noreferrer\" target=\"_blank\">Transcript in the machine: How AI paved the way for customized mRNA cancer treatments</a> by Søren Hough</p><p><br></p><p><a href=\"https://www.bioxconomy.com/modalities/mrna-hiv-vaccine-clears-hurdles-in-proof-of-concept-clinical-trials\" rel=\"noopener noreferrer\" target=\"_blank\">mRNA HIV vaccine clears hurdles in proof-of-concept clinical trials</a> by Søren Hough</p><p><br></p><p>You can find a fully annotated transcript of the episode <a href=\"https://www.bioxconomy.com/modalities/dose-of-discovery-katalin-kariko-on-the-mrna-breakthrough-that-changed-medicine\" rel=\"noopener noreferrer\" target=\"_blank\">here</a>.</p>","author_name":"Søren Hough"}